Follow-up of leucocyte and reticulocyte counts for the prediction of early graft failure after non-HLA-identical BMT in children

Bone Marrow Transplantation

Volumn 17, Issue 5, 1996, Pages 781-787

  Gerritsen, E J A ^a,e   Stam, E D ^a   Hermans, J ^b   Van Den Berg, H ^a,c   Haraldsson, A ^a,d   Van Tol, M J D ^a   Vossen, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Landspitalmn ^*  (Iceland)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Graft rejection; Leucocyte; Prediction; Reticulocyte

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP ABO SYSTEM; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; GRAFT FAILURE; GRAFT REJECTION; GRANULOCYTE; HLA SYSTEM; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RETICULOCYTE COUNT;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; GRAFT REJECTION; HLA ANTIGENS; HUMANS; INFANT; LEUKEMIA; LEUKOCYTE COUNT; RETICULOCYTE COUNT; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029976798     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Vossen JMJJ. Bone marrow transplantation in children. In Broyer M (ed). Baillière's Clinical Paediatrics. Baillière Tindall: London, 1993, pp 1029-1059.
2. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantations from related donors other than HLA-identical siblings. New Engl J Med 1985; 313: 197-204.
3. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. New Engl J Med 1993; 328: 593-602.
4. Vallera DA, Blazar BR. T cell depletion for graft-versus-host disease prophylaxis. Transplantation 1989; 47: 751-760.
5. Kaminski E, Hows J, Man S et al. Prediction of graft versus host disease by frequency analysis of cytotoxic T-cells after unrelated donor bone marrow transplantation. Transplantation 1989; 48: 608-613.
6. Wagemaker G, Heidt PJ, Merchav S, Bekkum DW Van. Abrogation of histo-incompatibility barriers in Rhesus monkeys. In: Baum SJ, Ledney GD, Thierfelder S (eds). Experimental Haematolagy Today. Karger: Basel, 1982, pp 311-118.
7. Morgan G, Linch DC, Knott LT et al. Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using Campath-1 monoclonal antibody and E-rosetting. Br J Haematol 1986; 62: 421-430.
8. Fischer A, Friedrich W, Fasth A et al. Reduction of graft failure by monoclonal antibody (anti-LFA-1 CD1la) after HLA non-identical bone marrow transplantation in children with immunodeficiencies, osteopetrosis and Fanconi's anemia: European group for immunodeficiency/European group for bone marrow transplantation report. Blood 1991; 77: 249-256.
9. Keman NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T-cell depleted HLA-nomdentical marrow transplants for leukemia. Transplantation 1987; 43: 482-487.
10. Kernan NA, Bordignon C, Heller G et al. Graft failure after T-cell-depleted human leucocyte antigen identical marrow transplants for leukemia. I. Analysis of risk factors and results of secondary transplants. Blood 1989; 74: 2227-2236.
11. Storb R, Thomas ED, Weiden PL et al. Allogeneic marrow grafting for treatment of aplastic anemia. Blood 1974; 43: 157-161.
12. Leeuwen JEM Van, Tol MJD Van, Joosten AM et al. Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematological malignancies of children is not correlated with relapse. Blood 1993; 82: 1921-1928.
13. Vossen JM, Heidt PJ, Berg H Van Den et al. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1990; 9: 14-23.
14. Berg H Van Den, Kluin PHM, Vossen JM. Early reconstitution of haematopoiesis after allogeneic bone marrow transplantation: a prospective histopathological study of bone marrow biopsy specimens. J Clin Pathol 1990; 43: 365-369.
15. Dyer MJS, Hale G, Hayhoe FGJ et al. Effect of Campath1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood 1989; 73: 1431-1439.
16. Gerritsen WR, O'Reilly RJ. Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL-1). IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T-cells. Blood 1994; 84: 1906-1912.
17. Cobbold S, Martin G, Waldmann H. Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection: the depletion of T-cell subsets in vitro and vivo. Transplantation 1986; 42: 239-247.
18. Bozdech MJ, Sondel PM, Trigg ME et al. Transplantation of HLA haplo-identical T-cell depleted marrow for leukaemia: addition of cytosine arabinoside to the pre-transplant conditioning prevents rejection. Exp Hematol 1985; 13: 1201-1210.
19. Soiffer RJ, Mauch P, Tarbell NJ et al. Total lymphoid irradiation to prevent graft rejection in recipients of HLA nonidentical T-cell-depleted allogeneic marrow. Bone Marrow Transplant 1991; 7: 23-33.
20. Verdonck LF, Gast GC De, Heugten HG Van et al. A fixed low number of T-cells in HLA-identical allogeneic bone marrow transplantation. Blood 1990; 75: 776-780.
21. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
22. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukaemia or Iymphoma. New Engl J Med 1989; 320: 197-204.
23. Uharek L, Gassmann W, Glass B, Steinmann J et al. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 1992; 79: 1612-1621.
24. Champlin RE, Horowitz MM, Bekkum DW Van et al. Graft failure following BMT for SAA: risk factors and treatment results. Blood 1989; 7: 606-613.
25. Atkinson K, Downs K, Ashby M et al. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly and those with chronic myeloid leukaemia more slowly than those with acute leukaemia. Bone Marrow Transplant 1989; 4: 23-27.
26. Sniecinsky IJ, Oien L, Petz LD et al. Immunohematologic consequences of major ABO mismatched bone marrow transplantation. Transplantation 1988; 45: 530-534.
27. Gerritsen WR, Wagemaker G, Jonker M et al. The repopulating capacity of autologous bone marrow grafts following pretreatment with monoclonal antibodies against T lymphocytes in rhesus monkeys. Transplantation 1988; 45: 301-307.
28. Bunjes D, Heit W, Arnold R et al. Evidence of the involvement of host derived OKTS positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation 1987; 43: 501-505.
29. Bordignon C, Keever CA, Small TN et al. Graft failure after T-cell-depleted HLA identical marrow transplants for leukemia: II. In vitro analysis of host effector mechanisms. Blood 1989; 74: 2237-2243.
30. Fleischhauer K, Kernan NA, O'Reilly RJ et al. Bone marrow allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. New Engl J Med 1990; 323: 1818-1822.
31. Aotsuka N, Asai T, Oh H et al. Lymphocyte subset reconstitution following human allogeneic bone marrow transplantation: differences between engrafted patients and graft failure patients. Bone Marrow Transplant 1991; 8: 345-349.
32. Gerritsen EJA, Stam ED, Hermans J et al. Risk factors for the development of EBV-related B-cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children. Bone Marrow Transplant 1996 (in press).
33. Uharek L, Gassmann W, Fleischhauer D et al. Effect of posttransplant methotrexate, cyclosporine A and prednisolone on graft rejection after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 7: 17-22.